Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human CD2 Fc Chimera Protein, CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Applications: Bioactivity

Manufacturer:  R&D Systems™ 1856CD050

Catalog No. 18-56C-D050


Add to cart
This item is not returnable. View return policy

Description

Description

The Recombinant Human CD2 Fc Chimera Protein is derived from HEK293. The Recombinant Human CD2 Fc Chimera Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

P06729
48 kDa
50 μg
12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
<0.10 EU per 1 μg of the protein by the LAL method.
CD2
Human
Reconstitute at 200 μg/mL in PBS.
914
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
HEK293
RUO
Bioactivity
Unconjugated
Yes
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit